Comparing two treatments for diabetic eye swelling after initial injections
Part of Eyes & vision clinical trials.
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have type 1 or type 2 diabetes
- You had severe diabetic macular edema (central retina thickness of 400 microns or more) at the start
- You started anti-VEGF injections within the last year and now your central retina thickness is below 400 microns but swelling remains
- You have not had anti-VEGF injections before this episode of severe swelling
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
This trial compares two standard anti-VEGF injections (aflibercept and bevacizumab) for people with diabetic macular edema who have not recently had this treatment. The goal is to see which drug works better over three monthly doses to improve vision and reduce retinal swelling.
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This trial tests a gentle laser treatment called micropulse laser for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It may help improve vision without the need for injections.
This study tests whether one eye injection (aflibercept) works better than another (bevacizumab) for people with diabetic macular edema. Both are already used for this condition, and the goal is to see which provides better vision improvement.
Hear when a new Severe Diabetic Macular Oedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.